Condition
Pediatric Pulmonary Hypertension
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04039464Phase 3CompletedPrimary
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
NCT02909608CompletedPrimary
Actigraphy in Pediatric Pulmonary Hypertension
NCT03431649Phase 4CompletedPrimary
Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children
Showing all 3 trials